First North American experience with the Berlin Heart EXCOR Active driver

Area of Science:

• Pediatric Cardiology
• Mechanical Circulatory Support
• Medical Device Technology

Background:

• The Berlin Heart EXCOR hinspace is a primary durable ventricular assist device for pediatric patients.
• The traditional IKUS driving unit has limitations in portability and battery life.
• The EXCOR hinspace Active offers extended battery life, enhancing device mobility.

Purpose of the Study:

• To report the initial North American clinical experience with the EXCOR hinspace Active mobile driving unit in pediatric patients.
• To evaluate the safety and operational aspects of the EXCOR hinspace Active.
• To assess the impact of the EXCOR hinspace Active on patient and caregiver mobility.

Main Methods:

• Retrospective chart review of pediatric patients using the Berlin Heart EXCOR hinspace device.
• Inclusion criteria: Patients supported by Berlin Heart and transitioned to the EXCOR hinspace Active.
• Data collected on transition times, support duration, safety, and operational issues.

Main Results:

• Seven pediatric patients were supported with the EXCOR hinspace Active between October 2022 and March 2024.
• Median transition time from IKUS to EXCOR hinspace Active was 12.0 days.
• No significant safety issues or major operational problems were observed with the EXCOR hinspace Active.

Conclusions:

• The EXCOR hinspace Active is a safe and feasible mobile driving unit for pediatric patients with Berlin Heart devices.
• Transition to the EXCOR hinspace Active significantly improved patient and caregiver mobility within the hospital.
• The EXCOR hinspace Active has the potential to enhance the quality of life for pediatric patients awaiting heart transplantation.